Clearside Biomedical, Inc. (CLSD)
Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.
Address
900 NORTH POINT PARKWAY
ALPHARETTA, GA 30005
Founded
2011
Number of Employees
30
Website
http://www.clearsidebio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)